Literature DB >> 16517601

NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity.

Lai Wei1, Matthew R Sandbulte, Paul G Thomas, Richard J Webby, Ramin Homayouni, Lawrence M Pfeffer.   

Abstract

Interferons (IFNs) are antiviral cytokines that selectively regulate gene expression through several signaling pathways including nuclear factor kappaB(NFkappaB). To investigate the specific role of NFkappaB in IFN signaling, we performed gene expression profiling after IFN treatment of embryonic fibroblasts derived from normal mice or mice with targeted deletion of NFkappaB p50 and p65 genes. Interestingly, several antiviral and immunomodulatory genes were induced higher by IFN in NFkappaB knock-out cells. Chromatin immunoprecipitation experiments demonstrated that NFkappaB was basally bound to the promoters of these genes, while IFN treatment resulted in the recruitment of STAT1 and STAT2 to these promoters. However, in NFkappaB knock-out cells IFN induced STAT binding as well as the binding of the IFN regulatory factor-1 (IRF1) to the IFN-stimulated gene (ISG) promoters. IRF1 binding closely correlated with enhanced gene induction. Moreover, NFkappaB suppressed both antiviral and immunomodulatory actions of IFN against influenza virus. Our results identify a novel negative regulatory role of NFkappaB in IFN-induced gene expression and biological activities and suggest that modulating NFkappaB activity may provide a new avenue for enhancing the therapeutic effectiveness of IFN.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517601      PMCID: PMC1457055          DOI: 10.1074/jbc.M513286200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.

Authors:  G T Belz; W Xie; J D Altman; P C Doherty
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Immune and other responses to viral infections.

Authors:  H L Ploegh
Journal:  Nutr Rev       Date:  2000-02       Impact factor: 7.110

3.  Interferon alpha /beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt.

Authors:  C H Yang; A Murti; S R Pfeffer; J G Kim; D B Donner; L M Pfeffer
Journal:  J Biol Chem       Date:  2001-01-30       Impact factor: 5.157

4.  IFNalpha/beta promotes cell survival by activating NF-kappa B.

Authors:  C H Yang; A Murti; S R Pfeffer; L Basu; J G Kim; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 5.  Mx proteins: mediators of innate resistance to RNA viruses.

Authors:  O Haller; M Frese; G Kochs
Journal:  Rev Sci Tech       Date:  1998-04       Impact factor: 1.181

Review 6.  The state of the STATs: recent developments in the study of signal transduction to the nucleus.

Authors:  C M Horvath; J E Darnell
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

7.  Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling.

Authors:  E De Smaele; F Zazzeroni; S Papa; D U Nguyen; R Jin; J Jones; R Cong; G Franzoso
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

8.  Inhibition of JNK activation through NF-kappaB target genes.

Authors:  G Tang; Y Minemoto; B Dibling; N H Purcell; Z Li; M Karin; A Lin
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

9.  Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells.

Authors:  Elena A Govorkova; Hong-Bin Fang; Ming Tan; Robert G Webster
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

10.  Modification of the Stat1 SH2 domain broadly improves interferon efficacy in proportion to p300/CREB-binding protein coactivator recruitment.

Authors:  Yong Zhang; Kazutaka Takami; Mindy S Lo; Guangming Huang; Qing Yu; William T Roswit; Michael J Holtzman
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

View more
  50 in total

Review 1.  The role of nuclear factor κB in the interferon response.

Authors:  Lawrence M Pfeffer
Journal:  J Interferon Cytokine Res       Date:  2011-06-01       Impact factor: 2.607

2.  Control of type I interferon-induced cell death by Orai1-mediated calcium entry in T cells.

Authors:  Chanyu Yue; Jonathan Soboloff; Ana M Gamero
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

3.  Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses.

Authors:  Suresh H Basagoudanavar; Roshan J Thapa; Shoko Nogusa; Junmei Wang; Amer A Beg; Siddharth Balachandran
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

Review 4.  Crosstalk in NF-κB signaling pathways.

Authors:  Andrea Oeckinghaus; Matthew S Hayden; Sankar Ghosh
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

5.  EHMT1 protein binds to nuclear factor-κB p50 and represses gene expression.

Authors:  Chee-Kwee Ea; ShengLi Hao; Kok Siong Yeo; David Baltimore
Journal:  J Biol Chem       Date:  2012-07-16       Impact factor: 5.157

6.  IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathway.

Authors:  Cynthia Brisac; Shadi Salloum; Victor Yang; Esperance A K Schaefer; Jacinta A Holmes; Stephane Chevaliez; Jian Hong; Charlie Carlton-Smith; Nadia Alatrakchi; Annie Kruger; Wenyu Lin; Raymond T Chung
Journal:  J Hepatol       Date:  2016-07-09       Impact factor: 25.083

7.  The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state.

Authors:  Sabine Eva Dudek; Christina Luig; Eva-Katharina Pauli; Ulrich Schubert; Stephan Ludwig
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

8.  Exacerbated innate host response to SARS-CoV in aged non-human primates.

Authors:  Saskia L Smits; Anna de Lang; Judith M A van den Brand; Lonneke M Leijten; Wilfred F van IJcken; Marinus J C Eijkemans; Geert van Amerongen; Thijs Kuiken; Arno C Andeweg; Albert D M E Osterhaus; Bart L Haagmans
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

9.  Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling.

Authors:  Dirk Holzinger; Carl Jorns; Silke Stertz; Stéphanie Boisson-Dupuis; Robert Thimme; Manfred Weidmann; Jean-Laurent Casanova; Otto Haller; Georg Kochs
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

10.  Specific NFkappaB subunit activation and kinetics of cytokine induction in adenoviral keratitis.

Authors:  Jaya Rajaiya; Neda Sadeghi; James Chodosh
Journal:  Mol Vis       Date:  2009-12-25       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.